Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$2.63 USD
+0.04 (1.54%)
Updated Aug 23, 2024 03:06 PM ET
After-Market: $2.64 +0.01 (0.38%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
NERV 2.63 +0.04(1.54%)
Will NERV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NERV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NERV
Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
NERV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Roche (RHHBY) Gets Positive CHMP Recommendation for Its Drugs
Roche's (RHHBY) Ocrevus Subcutaneous Gets European Commission Nod
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
Other News for NERV
Hold Rating on Minerva Neurosciences Amid Regulatory Uncertainty and Financial Constraints
Minerva price target lowered by $2 at H.C. Wainwright, here's why
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
Minerva Neurosciences: Q2 Earnings Snapshot
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates